Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Minireview: RET: normal and abnormal functions.

Massimo Santoro1, Rosa Marina Melillo, Francesca Carlomagno

  • 1Dipartimento di Biologia e Patologia Cellulare e Molecolare, University Federico II c/o Istituto di Endocrinologia ed Oncologia Sperimentale del Consiglio Nazionale delle Ricerche, Naples, Italy. masantor@unina.it

Endocrinology
|August 28, 2004
PubMed
Summary

The RET gene, a receptor tyrosine kinase, drives thyroid cancers like papillary and medullary thyroid carcinoma. Understanding RET oncogenic conversion and targeting RET are key strategies for thyroid cancer treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mining cancer genomes for copy number alterations identifies glycosylation enzymes as oncogenic drivers.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Inhibition of HMGA2 Leads to Reduced Cell Proliferation and Increased Apoptosis in Human Embryonal Carcinoma Cell Lines.

Andrology·2026
Same author

Discovery of a Proteolysis Targeting Chimera for TRKA and RET-derived oncoproteins.

Scientific reports·2025
Same author

Potential therapeutic targets and biomarkers in testicular germ cell tumor oncogenesis.

Expert opinion on therapeutic targets·2025
Same author

Iron and Cell Death.

Advances in experimental medicine and biology·2025
Same author

Targeting the Liver Serine Protease TMPRSS6 Ameliorates Steatosis and Attenuates Fibrosis in Experimental MASLD.

Liver international : official journal of the International Association for the Study of the Liver·2025

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • The RET gene encodes a receptor tyrosine kinase involved in cell growth and differentiation.
  • RET alterations are oncogenic, leading to various thyroid cancers, including papillary and medullary thyroid carcinoma.
  • Germline mutations in RET are causative for inherited multiple endocrine neoplasia type 2 syndromes.

Purpose of the Study:

  • To review mechanisms of RET oncogenic conversion.
  • To discuss RET targeting as a therapeutic strategy for thyroid cancer.
  • To provide an overview of RET's role in thyroid tumorigenesis.

Main Methods:

  • Literature review of studies on RET gene function.
  • Analysis of data on RET mutations and their clinical implications.

Related Experiment Videos

  • Synthesis of information on RET-targeted therapies.

    • Main Results:

    • RET oncogenic conversion occurs through various mechanisms, including mutations and fusions.
    • RET alterations are critical drivers in the development of papillary and medullary thyroid carcinomas.
    • Targeting RET signaling pathways shows promise in preclinical and clinical settings.

    Conclusions:

    • RET is a pivotal oncogene in thyroid cancer pathogenesis.
    • Targeting RET offers a promising therapeutic avenue for patients with RET-driven thyroid cancers.
    • Further research into RET biology and targeted therapies is warranted.